GlassScriptPhysician profile
Ashley Dawn Witkowski
NPI 1578113338
$228.37
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.60 · 2022: $130.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $66.93 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.91 | 2021 | |
| Tris Pharma INC | $17.36 | 2022 | |
| Seqirus USA INC | $17.14 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.52 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.33 | 2021 | |
| Cranial Technologies, INC | $15.12 | 2022 | |
| Merck Sharp & Dohme LLC | $15.00 | 2021 | |
| Corium, LLC | $13.84 | 2022 | |
| Pfizer INC. | $11.15 | 2021 | |
| Genentech USA, INC. | $5.07 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Witkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.